{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:06:02Z","timestamp":1760609162304,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cct.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:08:36Z","timestamp":1559092116000},"page":"101-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hellenic Postprandial Lipemia Study (HPLS): Rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Genovefa","family":"Kolovou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Giannakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Kalogeropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Anagnostopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Goumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kazianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria","family":"Limberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Mihas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Bilianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2019.05.011_bb0005","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cct.2019.05.011_bb0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/157016111795495549","article-title":"Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement","volume":"9","author":"Kolovou","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.cct.2019.05.011_bb0015","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2019.05.011_bb0020","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"year":"2014","series-title":"Clinical Guideline CG181: Lipid Modification - Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease","author":"National Institute for Health and Care Excellence (NICE)","key":"10.1016\/j.cct.2019.05.011_bb0025"},{"key":"10.1016\/j.cct.2019.05.011_bb0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cct.2019.05.011_bb0035","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement","volume":"316","author":"Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.cct.2019.05.011_bb0040","first-page":"39033","article-title":"2018AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","author":"Grundy","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cct.2019.05.011_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5551\/jat.RV16003","article-title":"Postprandial hyperlipidemia and remnant lipoproteins","volume":"24","author":"Masuda","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.cct.2019.05.011_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2014.01.015","article-title":"Postprandial hypertriglyceridemia as a coronary risk factor","volume":"431","author":"Bor\u00e9n","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"39","key":"10.1016\/j.cct.2019.05.011_bb0055","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"Cooney MT; ESC scientific document group. 2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cct.2019.05.011_bb0060","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cct.2019.05.011_bb0065","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2019.05.011_bb0070","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and Investigators. Evolocumab and clinical outcomes in patients with Cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2019.05.011_bb0075","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","article-title":"Cardiovascular efficacy and safety of Bococizumab in high-risk patients","volume":"376","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2019.05.011_bb0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2019.05.011_bb0085","first-page":"1119","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017"},{"key":"10.1016\/j.cct.2019.05.011_bb0090","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cct.2019.05.011_bb0095","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2019.05.011_bb0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.cct.2019.05.011_bb0105","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867054546609","article-title":"Clinical relevance of postprandial lipaemia","volume":"12","author":"Kolovou","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.cct.2019.05.011_bb0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0031-1273770","article-title":"Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome","volume":"119","author":"Kato","year":"2011","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"10.1016\/j.cct.2019.05.011_bb0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2337\/dc11-2556","article-title":"Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial","volume":"36","author":"Reyes-Soffer","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cct.2019.05.011_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1074248411399762","article-title":"Effect of atorvastatin monotherapy and low-dose atorvastatin\/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia","volume":"17","author":"Lee","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"7\u20138","key":"10.1016\/j.cct.2019.05.011_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.20452\/pamw.739","article-title":"Postprandial lipemia in diabetic men during hypolipemic therapy","volume":"119","author":"Skoczy\u0144ska","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"1","key":"10.1016\/j.cct.2019.05.011_bb0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2008.04.035","article-title":"The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients","volume":"202","author":"Hajer","year":"2009","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.cct.2019.05.011_bb0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MCA.0b013e328258fe41","article-title":"Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events","volume":"18","author":"Liu","year":"2007","journal-title":"Coron. Artery Dis."},{"issue":"1","key":"10.1016\/j.cct.2019.05.011_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2003.09.008","article-title":"Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects","volume":"93","author":"Schaefer","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.cct.2019.05.011_bb0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.cct.2019.05.011_bb0150","article-title":"Alterations in plasma triglyceride concentrations following two oral meals with different fat content in patients with type 2 diabetes mellitus","author":"Gavra","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.cct.2019.05.011_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11745-017-4275-9","article-title":"Assessment of the validity and reproducibility of a novel standardized test meal for the study of postprandial triacylglycerol concentrations","volume":"52","author":"Tentolouris","year":"2017","journal-title":"Lipids."},{"key":"10.1016\/j.cct.2019.05.011_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.cct.2019.05.011_bb0165","first-page":"55","article-title":"Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project)","volume":"48","author":"Panagiotakos","year":"2007","journal-title":"Hell. J. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2019.05.011_bb0170","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes Association. 2","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cct.2019.05.011_bb0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157016111795495530","article-title":"Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis","volume":"9","author":"Mihas","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.cct.2019.05.011_bb0180","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacl.2016.05.009","article-title":"Assessment of postprandial triglycerides in clinical practice: validation in a general population and coronary heart disease patients","volume":"10","author":"Perez-Martinez","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.cct.2019.05.011_bb0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.14310\/horm.2002.1713","article-title":"Postprandial dysmetabolism: assessment and treatment","volume":"15","author":"Katsiki","year":"2016","journal-title":"Hormones (Athens)."},{"key":"10.1016\/j.cct.2019.05.011_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2010.08.009","article-title":"Familial hypercholesterolemia and triglyceride metabolism","volume":"147","author":"Kolovou","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cct.2019.05.011_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-4-21","article-title":"Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects","volume":"4","author":"Kolovou","year":"2005","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cct.2019.05.011_bb0200","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714419300965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714419300965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T20:00:12Z","timestamp":1721332812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714419300965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":40,"alternative-id":["S1551714419300965"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2019.05.011","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hellenic Postprandial Lipemia Study (HPLS): Rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}